Serum interleukin-17 predicts severity and prognosis in patients with community acquired pneumonia: a prospective cohort study

Serum interleukin-17 predicts severity and prognosis in patients with community acquired pneumonia: a prospective cohort study

Abstract Background Some studies previously demonstrated that interleukin-17 (IL-17) involves in pulmonary diseases progression. Nevertheless, the role of IL-17 in community-acquired pneumonia (CAP) remains unknown. This study aims to examine the correlations between serum IL-17 with the severity an...

Full description

Bibliographic Details
Main Authors:	Chun-Mei Feng, Xin-Ming Wang, Meng-Die Li, Zheng Xu, Dong-Xu Hua, Jia-Yi Cheng, Ling Zheng, Hui Zhao, Lin Fu
Format:	Article
Language:	English
Published:	BMC 2021-12-01
Series:	BMC Pulmonary Medicine
Subjects:	Community-acquired pneumonia Interleukin-17 CAP severity scores Prognosis Biomarker
Online Access:	https://doi.org/10.1186/s12890-021-01770-6

Similar Items

The associations of serum S100A9 with the severity and prognosis in patients with community-acquired pneumonia: a prospective cohort study
by: Hong-Yan Liu, et al.
Published: (2021-04-01)

The association between serum complement C3a and severity in patients with community-acquired pneumonia
by: Zheng Xu, et al.
Published: (2023-01-01)

Relationship of Smoking Status and Severity of Inpatient Community Acquired Pneumonia (CAP)
by: Risa Septia Karisma, et al.
Published: (2023-08-01)

Role of Semi-quantitative Serum Procalcitonin in Assessing Prognosis of Community Acquired Bacterial Pneumonia Compared to PORT PSI, CURB-65 and CRB-65
by: Lalita Fernandes, et al.
Published: (2015-07-01)

The Associations of Serum IL-37 With the Severity and Prognosis in Patients With Community-Acquired Pneumonia: A Retrospective Cohort Study
by: Jia-Le Wang, et al.
Published: (2021-05-01)

Clinical Role of Serum Interleukin-17A in the Prediction of Refractory Mycoplasma pneumoniae Pneumonia in Children
by: Zhao J, et al.
Published: (2020-03-01)

Serum 8-iso-PGF2α Predicts the Severity and Prognosis in Patients With Community-Acquired Pneumonia: A Retrospective Cohort Study
by: Ling Zheng, et al.
Published: (2021-03-01)

Serum Level of 4-Hydroxynonenal in Community-Acquired Pneumonia: A Potential Biomarker for Severity and Prognosis
by: Ya-Lin Jiang, et al.
Published: (2022-06-01)

Evaluation of severity scoring systems in patients with severe community acquired pneumonia
by: Spasovska Katerina, et al.
Published: (2021-12-01)

Systemic interleukins levels in community-acquired pneumonia and their association with adverse outcomes
by: Tripon Raluca Elena, et al.
Published: (2019-04-01)

Prognostic factors in hospitalized community-acquired pneumonia: a retrospective study of a prospective observational cohort
by: Akihiro Ito, et al.
Published: (2017-05-01)

Cross-sectional and longitudinal associations of serum Cysteine-rich 61 with severity and prognosis among community-acquired pneumonia patients in China
by: Meng-Xing Yao, et al.
Published: (2022-08-01)

Features of laboratory indicators of severe community-acquired pneumonia
by: Pertzeva T.A., et al.
Published: (2017-06-01)

Community-acquired Pneumonia: Etiology, Prognosis and Therapy
by: Neşe SALTOĞLU, et al.
Published: (1999-12-01)

Associations of Serum Clara Cell Protein 16 with Severity and Prognosis in Adults with Community-Acquired Pneumonia
by: Li JF, et al.
Published: (2023-10-01)

Scored minor criteria for severe community-acquired pneumonia predicted better
by: Qi Guo, et al.
Published: (2019-01-01)

Interleukin 6, lipopolysaccharide-binding protein and interleukin 10 in the prediction of risk and etiologic patterns in patients with community-acquired pneumonia: results from the German competence network CAPNETZ
by: Zobel Katrin, et al.
Published: (2012-02-01)

The role of qSOFA score and biomarkers in assessing severity of community-acquired pneumonia in adults
by: Tripon Raluca-Elena, et al.
Published: (2021-01-01)

Pattern of community and hospital acquired pneumonia in Egyptian military hospitals
by: Magdy Mohammad Khalil, et al.
Published: (2013-01-01)

Predictive Value of Lysophosphatidylcholine for Determining the Disease Severity and Prognosis of Elderly Patients with Community-Acquired Pneumonia
by: Gu M, et al.
Published: (2024-03-01)

MiR-181b serves as diagnosis and prognosis biomarker in severe community-acquired pneumonia
by: Qiaolian Li, et al.
Published: (2021-08-01)

Assement of Severity of Community Acquired Pneumonia By CURB-65
by: Ahmed Talal Abdullah, et al.
Published: (2019-06-01)

Assement of Severity of Community Acquired Pneumonia By CURB-65
by: Ahmed Talal Abdullah, et al.
Published: (2019-06-01)

Community Acquired Pneumonia in the Emergency Department: value and limits of prognostic severity scores
by: R. Ferrari, et al.
Published: (2012-07-01)

The accuracy of severity assessment tools designed for community acquired pneumonia among elderly patients with hospital acquired pneumonia
by: Doha Rasheedy
Published: (2016-01-01)

Тhe features of severe community acquired pneumonia
by: Avramenko I.V.
Published: (2015-06-01)

Relationship between serum TNF-α, IL-6, and IL- 10 levels and disease severity, and changes in the cytokines after treatment in patients with bacterial community-acquired pneumonia
by: Bang Ngoc Dao*, et al.
Published: (2023-10-01)

Role of serum B-cell-activating factor and interleukin-17 as biomarkers in the classification of interstitial pneumonia with autoimmune features
by: Zhao Lihong, et al.
Published: (2024-02-01)

The frequency and seasonal distribution of viral infection in patients with community-acquired pneumonia and its impact on the prognosis
by: Kyung Jun Kim, et al.
Published: (2022-11-01)

PES Pathogens in Severe Community-Acquired Pneumonia
by: Catia Cillóniz, et al.
Published: (2019-02-01)

Association between neutrophil to lymphocyte ratio and mortality among community acquired pneumonia patients: a meta-analysis
by: Osama Alzoubi, et al.
Published: (2021-12-01)

Interleukin-6 and procalcitonin as biomarkers in mortality prediction of hospitalized patients with community acquired pneumonia
by: Ilija Andrijevic, et al.
Published: (2014-01-01)

Mycoplasma pneumoniae and Chlamydia spp. Infection in Community-Acquired Pneumonia, Germany, 2011–2012
by: Roger Dumke, et al.
Published: (2015-03-01)

Repeated Pneumonia Severity Index Measurement After Admission Increases its Predictive Value for Mortality in Severe Community-acquired Pneumonia
by: Chiung-Zuei Chen, et al.
Published: (2009-03-01)

The Effect of Interleukin-6 Gene Polymorphism on Pediatric Pneumonia
by: Guode SU, et al.
Published: (2019-11-01)

CAPPRIC Study—Characterization of Community-Acquired Pneumonia in Spanish Adults Managed in Primary Care Settings
by: Jesús Molina, et al.
Published: (2021-02-01)

The effect of taking antibacterial therapy on the outpatient stage and outcomes of community-acquired pneumonia in Tomsk hospitals
by: Daria A. Vinokurova, et al.
Published: (2024-01-01)

A high α1-antitrypsin/interleukin-10 ratio predicts bacterial pneumonia in adults with community-acquired pneumonia: a prospective cohort study
by: Taiga Miyazaki, et al.
Published: (2023-10-01)

The association between plasma D-dimer levels and community-acquired pneumonia
by: Sulhattin Arslan, et al.
Published: (2010-01-01)

Performance of Machine Learning Algorithms for Predicting Adverse Outcomes in Community-Acquired Pneumonia
by: Zhixiao Xu, et al.
Published: (2022-06-01)